Synvivo, Inc.
Publicly observedHuntsville, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Huntsville | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Synvivo, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | EHKCVZNSB5E5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Sept 2026Publicly observed
NIH SBIR/STTR award: Development of the First Standardized, Commercial Retinal Barrier-on-Chip Using Donor-Matched Human Primary Retinal Pigment Epithelial and Choroidal Endothelial Cells for AMD Therapeutic Testing
USD 290,400.00 · National Eye Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.